Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2
List of Figures 8
2 Introduction 9
2.1 What Is This Report About?
9
3 Definitions of Markets Covered in the Report 10
3.1 Diabetes Care
Devices 10
3.2 Glucose Monitoring Devices 10
3.2.1 Blood Glucose
Meters 10
3.2.2 Blood Glucose Strips 10
3.3 Insulin Delivery 10
3.3.1 Insulin Pens 10
3.3.2 Insulin Syringes 10
3.3.3 Insulin Pumps
10
3.3.4 Traditional Insulin Pump Accessories 11
4 Healthcare Sector
Review 12
5 Regulation System 13
5.1 Device Classification 13
5.2
Registration Process 13
5.3 Labeling Requirements 15
5.4 Import
Documentation 16
6 Pricing and Reimbursement 17
7 Distribution
Structure 18
8 Diabetes Care Devices In Mexico 19
8.1 Diabetes Care
Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 19
8.2
Diabetes Care Devices, Mexico, Overall Revenue ($ mn), 2000-2015 20
8.3
Diabetes Care Devices, Mexico, Category Volume (Units), 2000-2015 24
8.4
Diabetes Care Devices, Mexico, Company Share (2007-2008) 27
9 Glucose
Monitoring In Mexico 28
9.1 Glucose Monitoring Overall Revenue (2000-2015)
28
9.2 Glucose Monitoring Overall Volume (2000-2015) 30
9.3 Glucose
Monitoring Average Price (2000-2015) 32
9.4 Glucose Monitoring
Distribution Share (2007-2008) 33
9.5 Glucose Monitoring, Mexico, Company
Share (2007-2008) 34
10 Insulin Delivery In Mexico 35
10.1 Insulin
Delivery Overall Revenue (2000-2015) 35
10.1.1 Insulin Pens Overall
Revenue (2000-2015) 37
10.2 Insulin Delivery Overall Volume (2000-2015)
39
10.2.1 Insulin Pens Overall Volume (2000-2015) 40
10.3 Insulin
Delivery Average Price (2000-2015) 42
10.4 Insulin Delivery Distribution
Share (2007-2008) 43
10.5 Insulin Delivery, Mexico, Company Share
(2007-2008) 44
11 Overview of Key Companies in Mexico Diabetes Care
Devices Market 45
11.1 F. Hoffmann-La Roche Ltd. 45
11.1.1 Company
Overview 45
11.1.2 Value Chain Analysis 46
11.1.3 F. Hoffmann-La Roche
Ltd Pipeline Products 48
11.2 LifeScan, Inc. 49
11.2.1 Company
Overview 49
11.2.2 LifeScan, Inc. Pipeline Products 49
11.3 Bayer
HealthCare AG 51
11.3.1 Company Overview 51
11.3.2 Value Chain
Analysis 52
11.3.3 Bayer HealthCare AG Pipeline Products 54
11.4
Abbott Laboratories 55
11.4.1 Company Overview 55
11.4.2 Value Chain
Analysis 56
11.4.3 Abbott Laboratories Pipeline Products 58
11.5
Becton, Dickinson and Company 60
11.5.1 Company Overview 60
11.5.2
Value Chain Analysis 60
11.6 Medtronic, Inc. 62
11.6.1 Company
Overview 62
11.6.2 Value Chain Analysis 63
11.6.3 Medtronic, Inc.
Pipeline Products 65
11.7 Eli Lilly and Company 73
11.7.1 Company
Overview 73
11.7.2 Value Chain Analysis 73
11.7.3 Eli Lilly and
Company Pipeline Products 76
11.8 ARKRAY, Inc. 77
11.8.1 Company
Overview 77
11.8.2 ARKRAY, Inc. Pipeline Products 77
11.9 Terumo
Corporation 79
11.9.1 Company Overview 79
11.9.2 Value Chain Analysis
79
11.10 Animas Corporation 82
11.10.1 Company Overview 82
11.11
Sanofi-Aventis 82
11.11.1 Company Overview 82
11.12 Apex Biotechnology
Corp. 82
11.12.1 Company Overview 82
11.13 Smiths Medical 83
11.13.1 Company Overview 83
11.13.2 Value Chain Analysis 84
12
Appendix 86
12.1 Global Markets Direct Research Methodology 86
12.2
Coverage 87
12.3 Secondary Research 87
12.4 Primary Research 88
12.5 Models 88
12.6 Forecasts 89
12.7 Expert Panel Validation 89
12.8 Currency Conversion 90
12.9 Contact Us 91
12.10 Disclaimer 91
1.1 List of Tables
Table 1: Diabetes Care Devices,
Cross Country Comparison, Revenue ($ mn), 2000-2015 19
Table 2:
Diabetes Care Devices, Mexico, Overall Revenue ($ mn), 2000-2015 20
Table
3: Diabetes Care Devices, Mexico, Cross-Category Analysis, 2000-2015 21
Table 4: Diabetes Care Devices, Mexico, Overall Revenue ($ mn), Historic,
2000-2008 22
Table 5: Diabetes Care Devices, Mexico, Overall Revenue
($ mn), Forecast, 2008-2015 23
Table 6: Diabetes Care Devices,
Mexico, Category Volume (Units), 2000-2015 24
Table 7: Diabetes Care
Devices, Mexico, Category Volume (Units), Historic, 2000-2008 25
Table 8:
Diabetes Care Devices, Mexico, Category Volume (Units), Forecast,
2008-2015 26
Table 9: Diabetes Care Devices, Mexico, Company Share by
Revenue ($ mn), 2007-2008 27
Table 10: Glucose Monitoring, Mexico,
Revenue ($ mn) by Segment, Historic, 2000-2008 28
Table 11: Glucose
Monitoring, Mexico, Revenue ($ mn) by Segment, Forecast, 2008-2015 29
Table 12: Glucose Monitoring, Mexico, Volume (Units) by Segment,
Historic, 2000-2008 30
Table 13: Glucose Monitoring, Mexico, Volume
(Units) by Segment, Forecast, 2008-2015 31
Table 14: Glucose
Monitoring, Mexico, Average Price ($), Historic, 2000-2008 32
Table 15:
Glucose Monitoring, Mexico, Average Price ($), Forecast, 2008-2015 32
Table 16: Glucose Monitoring, Mexico, Distribution Share by Revenue
($mn), 2007-2008 33
Table 17: Glucose Monitoring, Mexico, Company
Share by Revenue ($ mn), 2007-2008 34
Table 18: Insulin Delivery,
Mexico, Revenue ($ mn) by Segment, Historic, 2000-2008 35
Table 19:
Insulin Delivery, Mexico, Revenue ($ mn) by Segment, Forecast, 2008-2015
36
Table 20: Insulin Pens, Mexico, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 37
Table 21: Insulin Pens, Mexico, Revenue ($ mn)
by Sub-Segment, Forecast, 2008-2015 38
Table 22: Insulin Delivery,
Mexico, Volume (Units) by Segment, Historic, 2000-2008 39
Table 23:
Insulin Delivery, Mexico, Volume (Units) by Segment, Forecast, 2008-2015
39
Table 24: Insulin Pens, Mexico, Volume (Units) by Sub-Segment,
Historic, 2000-2008 40
Table 25: Insulin Pens, Mexico, Volume (Units)
by Sub-Segment, Forecast, 2008-2015 41
Table 26: Insulin Delivery,
Mexico, Average Price ($), Historic, 2000-2008 42
Table 27: Insulin
Delivery, Mexico, Average Price ($), Forecast, 2008-2015 42
Table 28:
Insulin Delivery, Mexico, Distribution Share by Revenue ($mn), 2007-2008
43
Table 29: Insulin Delivery, Mexico, Company Share by Revenue ($
mn), 2007-2008 44
Table 30: F. Hoffmann-La Roche Ltd Pipeline
Products by Equipment Type 48
Table 31: F. Hoffmann-La Roche Ltd
Pipeline Products by Development Stage 48
Table 32: F. Hoffmann-La
Roche Ltd Pipeline Products by Therapy Area 48
Table 33: LifeScan,
Inc. Pipeline Products by Equipment Type 49
Table 34: LifeScan, Inc.
Pipeline Products by Development Stage 49
Table 35: LifeScan, Inc.
Pipeline Products by Therapy Area 49
Table 36: LifeScan, Inc.
Pipeline Products by Clinical Trials 50
Table 37: LifeScan, Inc.
Pipeline Products by News Summary 50
Table 38: Bayer HealthCare AG
Pipeline Products by Equipment Type 54
Table 39: Bayer HealthCare AG
Pipeline Products by Development Stage 54
Table 40: Bayer HealthCare
AG Pipeline Products by Therapy Area 54
Table 41: Bayer HealthCare AG
Pipeline Products by News Summary 54
Table 42: Abbott Laboratories
Pipeline Products by Equipment Type 58
Table 43: Abbott Laboratories
Pipeline Products by Development Stage 58
Table 44: Abbott
Laboratories Pipeline Products by Therapy Area 58
Table 45: Abbott
Laboratories Pipeline Products by Clinical Trials 59
Table 46: Abbott
Laboratories Pipeline Products by News Summary 59
Table 47:
Medtronic, Inc. Pipeline Products by Equipment Type 65
Table 48:
Medtronic, Inc. Pipeline Products By Development Stage 67
Table 49:
Medtronic, Inc. Pipeline Products By Therapy Area 69
Table 50:
Medtronic, Inc. Pipeline Products By Clinical Trials 71
Table 51:
Medtronic, Inc. Pipeline Products By News Summary 72
Table 52: Eli
Lilly and Company Pipeline Products by Equipment Type 76
Table 53:
Eli Lilly and Company Pipeline Products by Development Stage 76
Table 54:
Eli Lilly and Company Pipeline Products by Therapy Area 76
Table 55:
Eli Lilly and Company Pipeline Products by Clinical Trials 76
Table 56:
Eli Lilly and Company Pipeline Products by News Summary 76
Table 57:
ARKRAY, Inc. Pipeline Products by Equipment Type 77
Table 58:
ARKRAY, Inc. Pipeline Products by Development Stage 77
Table 59:
ARKRAY, Inc. Pipeline Products by Clinical Trials 78
Table 60:
ARKRAY, Inc. Pipeline Products by News Summary 78
Table 61: USD to Local
Currency, Average Exchange Rate 2008 90
1.2 List of
Figures
Figure 1: Diabetes Care Devices, Cross Country Comparison,
Revenue ($ mn), 2000-2015 19
Figure 2: Diabetes Care Devices, Mexico,
Overall Revenue ($ mn), 2000-2015 20
Figure 3: Diabetes Care Devices,
Mexico, Cross-Category Analysis, 2000-2015 21
Figure 4: Diabetes Care
Devices, Mexico, Overall Revenue ($ mn), Historic, 2000-2008 22
Figure 5:
Diabetes Care Devices, Mexico, Overall Revenue ($ mn), Forecast, 2008-2015
23
Figure 6: Diabetes Care Devices, Mexico, Category Volume (Units),
2000-2015 24
Figure 7: Diabetes Care Devices, Mexico, Category Volume
(Units), Historic, 2000-2008 25
Figure 8: Diabetes Care Devices,
Mexico, Category Volume (Units), Forecast, 2008-2015 26
Figure 9:
Diabetes Care Devices, Mexico, Company Share (%), 2008 27
Figure 10:
Glucose Monitoring, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2008
28
Figure 11: Glucose Monitoring, Mexico, Revenue ($ mn) by Segment,
Forecast, 2008-2015 29
Figure 12: Glucose Monitoring, Mexico, Volume
(Units) by Segment, Historic, 2000-2008 30
Figure 13: Glucose
Monitoring, Mexico, Volume (Units) by Segment, Forecast, 2008-2015 31
Figure 14: Glucose Monitoring, Mexico, Company Share (%), 2008 34
Figure 15: Insulin Delivery, Mexico, Revenue ($ mn) by Segment, Historic,
2000-2008 35
Figure 16: Insulin Delivery, Mexico, Revenue ($ mn) by
Segment, Forecast, 2008-2015 36
Figure 17: Insulin Pens, Mexico,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 37
Figure 18:
Insulin Pens, Mexico, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
38
Figure 19: Insulin Pens, Mexico, Volume (Units) by Sub-Segment,
Historic, 2000-2008 40
Figure 20: Insulin Pens, Mexico, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 41
Figure 21: Insulin
Delivery, Mexico, Company Share (%), 2008 44
Figure 22: F.
Hoffmann-La Roche Ltd Value Chain Analysis 46
Figure 23: Bayer
HealthCare AG Value Chain Analysis 52
Figure 24: Abbott Laboratories
Value Chain Analysis 56
Figure 25: Becton, Dickinson and Company
Value Chain Analysis 60
Figure 26: Medtronic, Inc. Value Chain
Analysis 63
Figure 27: Eli Lilly and Company Value Chain Analysis
73
Figure 28: Terumo Corporation Value Chain Analysis 79
Figure
29: Smiths Medical Value Chain Analysis 84
Figure 30: Global
Markets Direct Methodology 86
|
Related Report
|
View Cart
